KREBSBIO — Krebs Biochemicals And Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Krebs Biochemicals And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5.92	0.323	0.174	0.691	3.38
Net Total Accounts Receivable
Net Total Receivables	34.2	90.4	31	66.8	0.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	214	355	161	174	103
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,264	1,442	1,487	1,495	1,465
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,592	1,898	1,750	1,782	1,690
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	482	781	491	618	1,035
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,020	2,649	2,744	2,974	3,153
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-427	-751	-995	-1,192	-1,462
Total Liabilities & Shareholders' Equity	1,592	1,898	1,750	1,782	1,690
Total Common Shares Outstanding